🔴 Exclusive webinar: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

ICON PLC (ICLR)

NASDAQ
Currency in USD
212.18
-2.75(-1.28%)
Closed
Pre Market
214.09+1.91(+0.90%)
ICLR Scorecard
Full Analysis
RSI suggests the stock is in oversold territory
Fair Value
Day's Range
210.84217.91
52 wk Range
208.65347.72
Key Statistics
Edit
Prev. Close
212.18
Open
217
Day's Range
210.84-217.91
52 wk Range
208.65-347.72
Volume
1,325,505
Average Volume (3m)
940,437
1-Year Change
-17.23%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ICLR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
283.00
Upside
+33.38%
Members' Sentiments
Bearish
Bullish
ProTips
14 analysts have revised their earnings downwards for the upcoming period
Show more

ICON PLC Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

InvestingPro Research for ICON PLC


Biotech Resilience
ICON's Non-COVID segments outperform expectations, showcasing resilience amid industry shifts and strong demand from pharmaceutical giants
Financial Maneuvers
Debt refinancing boosts 2024 EPS guidance, demonstrating proactive capital management and enhancing financial flexibility
Strategic Growth Path
Explore ICON's focus on biotech M&A, potentially driving innovation, service expansion, and market position strengthening
Market Dynamics
Analysts project EPS of $15.06-$15.15 for FY1 and $16.97-$17.31 for FY2, with an average price target of $353, reflecting industry challenges and opportunities
Read full SWOT analysis

Compare ICLR to Peers and Sector

Metrics to compare
ICLR
Peers
Sector
Relationship
P/E Ratio
23.4x13.2x−0.6x
PEG Ratio
0.53−0.640.00
Price/Book
1.8x1.4x2.6x
Price / LTM Sales
2.1x3.0x3.2x
Upside (Analyst Target)
31.4%21.1%43.6%
Fair Value Upside
Unlock8.2%5.8%Unlock

FAQ

What Is the ICON PLC (ICLR) Stock Price Today?

The ICON PLC stock price today is 212.18.

What Stock Exchange Does ICON PLC Trade On?

ICON PLC is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for ICON PLC?

The stock symbol for ICON PLC is "ICLR."

What Is the ICON PLC Market Cap?

As of today, ICON PLC market cap is 17.52B.

What is ICON PLC Earnings Per Share?

The ICON PLC EPS is 9.05.

What Is the Next ICON PLC Earnings Date?

ICON PLC will release its next earnings report on 18 Feb 2025.

From a Technical Analysis Perspective, Is ICLR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.